Lifestyle Changes in Fatty Liver; Additive Effect of Honey Intake
- Conditions
- Fatty Liver, Nonalcoholic
- Interventions
- Behavioral: honey intake and lifestyle changesBehavioral: lifestyle changes
- Registration Number
- NCT06596109
- Lead Sponsor
- Cairo University
- Brief Summary
honey is a natural functional food used in control cardiovascular risk factors but its effect on fatty liver is not investigated
- Detailed Description
Forty fatty liver (non-alcoholic from) patients with obesity are included to be divided into group 1 who will contain 20 patients who will receive honey intake (orally, as a daily total dose of 2 g/kg, this dose will be divided to three equal subdoses, every dose will be administered before meal), low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks. Group 2 who will contain 20 patients who will receive low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 40
- fatty liver (non alcoholic form)
- both sexes included
- obese subjects (class I)
- cardiac insult
- respiratory insult
- renal insult
- lower limb insult
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description honey intake and lifestyle changes honey intake and lifestyle changes Twenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive honey intake (orally, as a daily total dose of 2 g/kg, this dose will be divided to three equal subdoses, every dose will be administered before meal), low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks. lifestyle changes lifestyle changes Twenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks.
- Primary Outcome Measures
Name Time Method High density lipoprotein it will be assessed after 12 weeks it will be measured in serum
- Secondary Outcome Measures
Name Time Method triglycerides it will be assessed after 12 weeks it will be measured in serum
cholesterol it will be assessed after 12 weeks it will be measured in serum
low density lipoprotein it will be assessed after 12 weeks it will be measured in serum
alanine transamianse it will be assessed after 12 weeks it will be measured in serum
aspartate transamianse it will be assessed after 12 weeks it will be measured in serum
fasting blood glucose it will be measured after 12 weeks it will be measured in serum
body mass index it will be measured after 12 weeks it will be measured on empty stomach
waist circumference it will be measured after 12 weeks it will be measured on empty stomach
Trial Locations
- Locations (1)
faculty of physical therapy Cairo university
🇪🇬Dokki, Giza, Egypt